Drug Optimization Sample Clauses

Drug Optimization. Dose adjustments for drug optimization are commonly supported by clinical guidelines for patients with uncontrolled disease states. As point-of-care laboratory testing becomes more common in community pharmacies, pharma- cists have the opportunity to identify uncon- trolled disease states and optimize therapy be- tween a patient’s visits with their physician. “My doctor can’t see me again for 3 months.” Xx. Xxxxxxxxxx was diagnosed with diabetes type 2 two weeks ago with fasting blood glucose greater than 500 mg/ dL. He was started on metformin 500mg twice daily and Lan- tus 10 units at bedtime. Despite taking his medications as prescribed without significant side effects, he continues to experience symptoms of hyperglycemia and fasting blood glu- cose readings in the 400s. Upon discussing the lack of control of his diabetes with his pharmacist, Xx. Xxxxxxxxxx expresses frustration that his doc- tor is not available to see him again for 3 months. To improve his diabetes control and prevent a potential hospital admis- sion, the pharmacist utilizes the CPA to increase his metformin dose. For instance, titrations for anti-diabetic medi- cations are often recommended over a few weeks, but patients are often only able to visit their physicians every 3-6 months. This delay in follow-up results in prolonged peri- ods without diabe- t e s c o n t r o l . Through a CPA based on clinical guidelines, pharma- cists can perform drug optimization interventions to ensure more effi- cient disease state control for chronic conditions, like dia- betes, hypertension, or hyperlipidemia.
Sample 1
AutoNDA by SimpleDocs

Related to Drug Optimization

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act.

  • Screening 3.13.1 Refuse containers located outside the building shall be fully screened from adjacent properties and from streets by means of opaque fencing or masonry walls with suitable landscaping.

  • Annual Production Program document describing the forecasts for Production and handling of Oil, Gas, water, special fluids, and waste arising from the Production process of each Development Area or Field.

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

  • Technology Research Analyst Job# 1810 General Characteristics Maintains a strong understanding of the enterprise’s IT systems and architectures. Assists in the analysis of the requirements for the enterprise and applying emerging technologies to support long-term business objectives. Responsible for researching, collecting, and disseminating information on emerging technologies and key learnings throughout the enterprise. Researches and recommends changes to foundation architecture. Supports research projects to identify and evaluate emerging technologies. Interfaces with users and staff to evaluate possible implementation of the new technology in the enterprise, consistent with the goal of improving existing systems and technologies and in meeting the needs of the business. Analyzes and researches process of deployment and assists in this process.

  • RE-WEIGHING PRODUCT Deliveries are subject to re- weighing at the point of destination by the Authorized User. If shrinkage occurs which exceeds that normally allowable in the trade, the Authorized User shall have the option to require delivery of the difference in quantity or to reduce the payment accordingly. Such option shall be exercised in writing by the Authorized User.

  • Drug Test The compulsory production and submission of urine and/or blood, in accordance with departmental procedures, by an employee for chemical analysis to detect prohibited drug usage.

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

Time is Money Join Law Insider Premium to draft better contracts faster.